The Worst IPO Of 2014

Now that 2014 is winding down, it’s a good time to look back at some of 2014’s most memorable IPOs. There plenty of IPO winners and losers this year, but only one company can lay claim to the title of worst IPO of 2014.

Worst IPO: Amedica (-88.2%)

Amedica Corporation AMDA 15.11% earns the dubious distinction of 2014’s worst IPO. Amedica is a medical technology company that specializes in spinal implants. The company holds patents on their Valeo silicon nitride spinal fusion line and is working to add total hip and knee replacement products in the future.

After withdrawing their IPO application back in 2007 because of “market conditions,” Amedica initially lowered its projected IPO price range from $10 to $12 down to $8 to $10.

When the company finally went public in February, IPO shares were priced at $5.75, well below any of the previously expected ranges. The stock opened trading at $6.16, but by the end of the first day was down to $5.39.

After surging as high as $9.37 in its first couple of weeks of trading, Amedica …

Read the rest of this article (and all my other articles) for free on Benzinga by clicking here

Want to learn more about the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and is always available on your local internet!